KOLIGO THERAPEUTICS, INC.

Profile

Company Names

KOLIGO THERAPEUTICS, INC.
KOLIGO THERAPEUTICS INC.

Addresses

2113 STATE STREET, NEW ALBANY, IN 47150

204 SOUTH FLOYD ST., LOUISVILLE, KY 40202

204 SOUTH FLOYD ST, LOUISVILLE, KY 40202

Phone Numbers

5022654830
5022425890
6463317899

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2016

State Incorporated:

KENTUCKY

Total Amount Raised:

$3,651,759.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2020-09-25 
$1,646,759.00 
$1,646,759.00 
$0.00 
Equity 
2
2018-03-06 
$2,000,000.00 
$2,000,000.00 
$0.00 
Debt 
1
2017-12-01 
$5,000.00 
$5,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BALAMURUGAN 
 
APPAKALAI 
DIRECTOR, EXECUTIVE OFFICER
KOLIGO THERAPEUTICS INC.
DAVID 
 
BLANFORD 
DIRECTOR, EXECUTIVE OFFICER
KOLIGO THERAPEUTICS INC.
MICHAEL 
 
HUGHES 
DIRECTOR, EXECUTIVE OFFICER
VERTIFLEX INC   |  SGF FUND, LP   |  BORESIGHT MINERALS, LLC   |  KOLIGO THERAPEUTICS INC.   |  PERIOVANCE, INC.   |  MAWSON INFRASTRUCTURE GROUP INC.   |  DOCKET SOFTWARE CORP.   |  ROOKERY LABS, INC.
MATTHEW 
 
LEHMAN 
EXECUTIVE OFFICER
KOLIGO THERAPEUTICS LTD   |  KOLIGO THERAPEUTICS, INC.   |  ALIGNED EXTERIORS GROUP LLC
MATTHEW 
B 
LEHMAN 
EXECUTIVE OFFICER, DIRECTOR
KOLIGO THERAPEUTICS INC.
STUART 
 
WILLIAMS 
DIRECTOR, EXECUTIVE OFFICER
CARMANAH TECHNOLOGIES CORP   |  KOLIGO THERAPEUTICS INC.   |  KOLIGO THERAPEUTICS LTD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-10-07
D
Link
BIOTECHNOLOGY 
 
$1,000,001 - $5,000,000 
Equity 
2020-09-25 
2018-03-07
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2018-03-06 
2017-12-14
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2017-12-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#